NYSE - Delayed Quote • USD
Bausch + Lomb Corporation (BLCO)
At close: May 31 at 4:00 PM EDT
After hours: May 31 at 7:57 PM EDT
Earnings Estimate
CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 7 | 7 | 8 | 9 |
Avg. Estimate | 0.17 | 0.21 | 0.86 | 1.2 |
Low Estimate | 0.14 | 0.19 | 0.82 | 1.14 |
High Estimate | 0.25 | 0.25 | 0.94 | 1.29 |
Year Ago EPS | 0.24 | 0.62 | 1 | 0.86 |
Revenue Estimate
CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 8 | 8 | 8 | 9 |
Avg. Estimate | 1.6B | 1.57B | 6.37B | 6.73B |
Low Estimate | 1.59B | 1.51B | 6.34B | 6.62B |
High Estimate | 1.62B | 1.6B | 6.41B | 6.78B |
Year Ago Sales | 1.4B | -- | 5.67B | 6.37B |
Sales Growth (year/est) | 13.90% | -- | 12.40% | 5.60% |
Earnings History
CURRENCY IN USD | 6/30/2023 | 9/30/2023 | 12/31/2023 | 3/31/2024 |
---|---|---|---|---|
EPS Est. | 0.18 | 0.26 | 0.24 | 0.07 |
EPS Actual | 0.24 | 0.62 | 0.33 | 0.1 |
Difference | 0.06 | 0.36 | 0.09 | 0.03 |
Surprise % | 33.30% | 138.50% | 37.50% | 42.90% |
EPS Trend
CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | 0.17 | 0.21 | 0.86 | 1.2 |
7 Days Ago | 0.17 | 0.21 | 0.86 | 1.21 |
30 Days Ago | 0.18 | 0.22 | 0.84 | 1.2 |
60 Days Ago | 0.21 | 0.22 | 0.82 | 1.18 |
90 Days Ago | 0.2 | 0.22 | 0.82 | 1.19 |
EPS Revisions
CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
CURRENCY IN USD | BLCO | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | -29.20% | -- | -- | 8.90% |
Next Qtr. | -66.10% | -- | -- | 11.40% |
Current Year | -14.00% | -- | -- | 5.80% |
Next Year | 39.50% | -- | -- | 12.60% |
Next 5 Years (per annum) | 1.50% | -- | -- | 11.45% |
Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
Reiterates | HC Wainwright & Co.: Buy | 2/2/2023 |
Initiated | Barclays: Equal-Weight | 12/21/2022 |
Maintains | Goldman Sachs: Neutral | 11/23/2022 |
Maintains | JP Morgan: Neutral | 11/3/2022 |
Maintains | RBC Capital: Outperform | 11/3/2022 |
Maintains | Morgan Stanley: Equal-Weight | 11/3/2022 |
Related Tickers
XRAY DENTSPLY SIRONA Inc.
28.01
+0.94%
ANIK Anika Therapeutics, Inc.
25.65
-0.23%
ALC Alcon Inc.
89.13
+0.88%
MMSI Merit Medical Systems, Inc.
81.15
+0.30%
STVN Stevanato Group S.p.A.
20.32
+3.83%
WRBY Warby Parker Inc.
17.71
+1.55%
TFX Teleflex Incorporated
209.07
+1.18%
UTMD Utah Medical Products, Inc.
68.29
+1.74%
NVST Envista Holdings Corporation
19.36
+2.54%
ATR AptarGroup, Inc.
147.69
+1.06%